Tag: ILUMYA
Sun Pharmaceutical declares 5-yr positive results for ILUMYA
Pharma major Sun Pharmaceutical Industries Limited has announced that one of its wholly owned subsidiaries presented positive, five-year Phase 3 data for ILUMYA (tildrakizumab-asmn)...
